| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,610,000 |
| Market
Cap: |
80.31(M) |
| Last
Volume: |
1,136,985 |
Avg
Vol: |
1,133,895 |
| 52
Week Range: |
$0.900001 - $2.955 |
|
| Level
I Sector: |
Consumer Discretionary |
| Level
II Sector: |
Media |
| Level
III Sector: |
Broadcasting - TV |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Brooklyn ImmunoTherapeutics is a clinical-stage biopharmaceutical company focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer, both as a single agent and in combination with other anti-cancer therapies. Co. is seeking to develop IRX-2, a cytokine-based therapy, to treat patients with cancer. Co. also is exploring opportunities to advance oncology, blood disorder, and monogenic disease therapies using gene-editing and cell therapy technology through a license with Factor Bioscience Limited and through its subsidairies, Novellus, Inc. and Novellus, Ltd.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
880,962 |
| Total Buy Value |
$0 |
$0 |
$0 |
$2,889,556 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Wolff Allen |
CFO |
• – – |
2015-05-21 |
4 |
B |
$0.36 |
$23,580 |
D/D |
65,500 |
65,500 |
2.74 |
- |
|
| Mitgang Steve |
Director |
– • – |
2015-05-15 |
4/A |
B |
$0.42 |
$6,300 |
D/D |
15,000 |
15,000 |
2.39 |
- |
|
| Mitgang Steve |
Director |
– • – |
2015-05-15 |
4 |
B |
$0.42 |
$2,100 |
D/D |
5,000 |
5,000 |
2.31 |
- |
|
| Berg Jeffrey Alan |
Director |
– • • |
2014-09-19 |
4 |
B |
$0.35 |
$6,310 |
I/I |
18,095 |
20,593,982 |
2.17 |
- |
|
| Berg Jeffrey Alan |
Director |
– • – |
2014-09-15 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
530,000 |
|
- |
|
| Gurrola Sandra M |
VP of FinanceOfficer |
• – – |
2014-09-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,184 |
|
- |
|
| Uphoff Tony |
Director |
– • – |
2014-06-10 |
4 |
B |
$0.52 |
$4,992 |
D/D |
9,600 |
9,600 |
2.31 |
- |
|
| Chandler Barry |
Chief Marketing Officer |
• – – |
2013-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
250,000 |
|
- |
|
| Berg Jeffrey Alan |
Interim CEO |
• • • |
2012-12-18 |
4 |
B |
$0.20 |
$691,726 |
I/I |
3,458,629 |
20,575,887 |
2.64 |
- |
|
| Yanover Paul |
Director |
– • – |
2012-12-14 |
4 |
GA |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
|
- |
|
| Berg Jeffrey Alan |
Interim CEO |
• • • |
2012-12-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
100,000 |
17,117,258 |
|
- |
|
| Berg Jeffrey Alan |
INTERIM CEO |
• • • |
2012-09-19 |
4 |
B |
$0.19 |
$1,908 |
I/I |
10,000 |
17,217,258 |
2.56 |
- |
|
| Berg Jeffrey Alan |
INTERIM CEO |
• • • |
2012-09-13 |
4 |
B |
$0.20 |
$305 |
I/I |
1,500 |
17,207,258 |
2.56 |
- |
|
| Berg Jeffrey Alan |
INTERIM CEO |
• • • |
2012-09-11 |
4 |
B |
$0.19 |
$9,878 |
I/I |
52,000 |
17,205,758 |
2.56 |
- |
|
| Berg Jeffrey Alan |
INTERIM CEO |
• • • |
2012-09-10 |
4 |
B |
$0.17 |
$188,816 |
I/I |
1,110,684 |
17,153,758 |
2.64 |
- |
|
| Berg Jeffrey Alan |
INTERIM CEO |
• • • |
2012-09-07 |
4 |
B |
$0.18 |
$179 |
I/I |
1,000 |
16,043,074 |
2.56 |
- |
|
| Berg Jeffrey Alan |
INTERIM CEO |
• • • |
2012-09-06 |
4 |
B |
$0.16 |
$2,169 |
I/I |
13,000 |
16,042,074 |
2.56 |
- |
|
| Berg Jeffrey Alan |
INTERIM CEO |
• • • |
2012-09-05 |
4 |
B |
$0.16 |
$701 |
I/I |
4,431 |
16,029,074 |
2.56 |
- |
|
| Khuchua Vladimir |
EVP and Chief Product Officer |
• – – |
2012-08-16 |
4 |
B |
$0.22 |
$924 |
D/D |
4,200 |
272,700 |
2.66 |
- |
|
| Khuchua Vladimir |
EVP/Chief Product Officer |
• – – |
2012-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
268,500 |
|
- |
|
| George Christopher Allen |
Chief Information Officer |
• – – |
2012-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
60,600 |
|
- |
|
| Berger Kendra |
Chief Financial Officer |
• – – |
2012-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
188,750 |
|
- |
|
| Khuchua Vladimir |
EVP and Chief Content Officer |
• – – |
2012-05-18 |
4 |
B |
$0.20 |
$700 |
D/D |
3,500 |
18,500 |
2.66 |
- |
|
| Berg Jeffrey Alan |
Director |
– • • |
2012-02-28 |
4 |
B |
$0.25 |
$2,000,000 |
I/I |
8,000,000 |
16,024,643 |
2.25 |
- |
|
| Bush Michael J |
CEO |
• • – |
2012-02-24 |
4 |
OE |
$0.25 |
$29,977 |
D/D |
119,907 |
420,385 |
|
- |
|
406 Records found
|
|
Page 10 of 17 |
|
|
0.11 (5.39%) 
